Back

The role of inflammation as treatment target in valve disease.

27 August 2018 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: Global perspectives on valvular heart disease Valvular Heart Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor David Newby

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Geographical variation in epidemiology and management of degenerative valve disease.
Professor Y. Wu (Beijing, CN)
Presentation thumbnail
TAVI for bicuspid aortic stenosis: Do or don't
Doctor M. Chen (Chengdu, CN)
Slides Video
Presentation thumbnail
Challenges in valve disease for the next decade
Professor B. Prendergast (London, GB)
Slides Video

Access the full session

Session thumbnail
Global perspectives on valvular heart disease

The Event

Event poster

ESC Congress 2018

27 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025
thumbnail
Webinar
2025 ESC Guidelines on Valvular heart disease: what’s new in aortic stenosis
10 December 2025
thumbnail
Congress Presentation
Wire injury induced moderate aortic valve stenosis in mice is accompanied by a chronic systemic inflammatory reaction
31 August 2024
thumbnail
Congress Presentation
Modeling aortic stenosis progression: impact on follow-up, treatment and survival
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources